MYLET JOHANNA (Senior Vice President, Finance) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/1/2022ACC: 0001209191-22-014376
Officer· Senior Vice President, Finance
Since Jul 2020
+122.57K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
122.57K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
146.1%
3/1/2022
34.23K→84.23K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2022 | A · Award | +50K | — | — | 146.1% | 34.23K | 84.23K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
72.57K shares
Shares
+72.57K
Strike price
3.42
Held after
72.57K
Exercisable
—
3/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock72.57K shares | 3/1/2022 | A · Award | +72.57K | 3.42 | — | 72.57K |